151 related articles for article (PubMed ID: 18071066)
21. Expression of Bcl-2 and p53 in the colorectal adenoma-carcinoma sequence.
Hao XP; Ilyas M; Talbot IC
Pathobiology; 1997; 65(3):140-5. PubMed ID: 9309780
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF
Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
[TBL] [Abstract][Full Text] [Related]
24. The prognostic value of the immunohistochemical aspects of tumor suppressor genes p53, bcl-2, PTEN and nuclear proliferative antigen Ki-67 in resected colorectal carcinoma.
Ghiţă C; Vîlcea ID; Dumitrescu M; Vîlcea AM; Mirea CS; Aşchie M; Vasilescu F
Rom J Morphol Embryol; 2012; 53(3):549-56. PubMed ID: 22990545
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors.
Menezes HL; Jucá MJ; Gomes EG; Nunes BL; Costa HO; Matos D
Arq Gastroenterol; 2010; 47(2):141-7. PubMed ID: 20721457
[TBL] [Abstract][Full Text] [Related]
26. Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma.
Hu YX; Watanabe H; Ohtsubo K; Yamaguchi Y; Ha A; Motoo Y; Okai T; Sawabu N
Br J Cancer; 1999 Jun; 80(7):1075-9. PubMed ID: 10362119
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the correlation between p53 and bcl-2 expression with staging and prognosis of the colorectal adenocarcinoma.
Lustosa SA; Logullo A; Artigiani R; Saad SS; Goldenberg A; Matos D
Acta Cir Bras; 2005; 20(5):353-7. PubMed ID: 16186958
[TBL] [Abstract][Full Text] [Related]
28. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U
Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232
[TBL] [Abstract][Full Text] [Related]
29. Cell kinetics, p53 and bcl-2 expression, and c-Ki-ras mutations in flat-elevated tubulovillous adenomas and adenocarcinomas of the colorectum: comparison with polypoid lesions.
Sada M; Mitomi H; Igarashi M; Katsumata T; Saigenji K; Okayasu I
Scand J Gastroenterol; 1999 Aug; 34(8):798-807. PubMed ID: 10499481
[TBL] [Abstract][Full Text] [Related]
30. Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer.
Moul JW; Bettencourt MC; Sesterhenn IA; Mostofi FK; McLeod DG; Srivastava S; Bauer JJ
Surgery; 1996 Aug; 120(2):159-66; discussion 166-7. PubMed ID: 8751578
[TBL] [Abstract][Full Text] [Related]
31. Tumour 'budding' and its relationship to p53 and Bcl-2 expression in colorectal cancer.
Guzińska-Ustymowicz K; Sulkowska M; Famulski W; Sulkowski S
Anticancer Res; 2003; 23(1B):649-53. PubMed ID: 12680162
[TBL] [Abstract][Full Text] [Related]
32. Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1).
Grizzle WE; Manne U; Weiss HL; Jhala N; Talley L
Int J Cancer; 2002 Feb; 97(4):403-9. PubMed ID: 11802199
[TBL] [Abstract][Full Text] [Related]
33. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
[TBL] [Abstract][Full Text] [Related]
34. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas.
Sinicrope FA; Hart J; Hsu HA; Lemoine M; Michelassi F; Stephens LC
Clin Cancer Res; 1999 Jul; 5(7):1793-804. PubMed ID: 10430084
[TBL] [Abstract][Full Text] [Related]
35. Altered subcellular localization of suppressin, a novel inhibitor of cell-cycle entry, is an independent prognostic factor in colorectal adenocarcinomas.
Manne U; Gary BD; Oelschlager DK; Weiss HL; Frost AR; Grizzle WE
Clin Cancer Res; 2001 Nov; 7(11):3495-503. PubMed ID: 11705868
[TBL] [Abstract][Full Text] [Related]
36. Using a combination of cytochrome P450 1B1 and beta-catenin for early diagnosis and prevention of colorectal cancer.
Chang H; Su JM; Huang CC; Liu LC; Tsai CH; Chou MC; Lin P
Cancer Detect Prev; 2005; 29(6):562-9. PubMed ID: 16289386
[TBL] [Abstract][Full Text] [Related]
37. p53, Bcl-2 and C-Myc expressions in colorectal carcinoma associated with schistosomiasis in Egypt.
Zalata KR; Nasif WA; Ming SC; Lotfy M; Nada NA; El-Hak NG; Leech SH
Cell Oncol; 2005; 27(4):245-53. PubMed ID: 16308474
[TBL] [Abstract][Full Text] [Related]
38. Bio-pathological factors of prognostic value in colorectal adenocarcinomas.
Mottolese M; Buglioli S; Piperno G; Sperduti I; Giannarelli D; D'Angelo C; Cosimelli M
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):163-6. PubMed ID: 16767924
[TBL] [Abstract][Full Text] [Related]
39. Lack of relation of AKAP12 with p53 and Bcl-2 in colorectal carcinoma.
Suren D; Yildirim M; Alikanoglu AS; Kaya V; Yildiz M; Dilli UD; Sezer C
Asian Pac J Cancer Prev; 2014; 15(8):3415-8. PubMed ID: 24870731
[TBL] [Abstract][Full Text] [Related]
40. Comparison of p53 and bcl-2 expression in initial, synchronous, and metachronous colorectal adenomas.
Watatani M; Ieda S; Kuroda K; Inui H; Nishimura K; Yasutomi M
Surg Today; 1999; 29(8):707-12. PubMed ID: 10483743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]